RxDoctor Payments Data

James Wood, MD

Interventional Pain Medicine · Virginia Beach, VANPI 1174186183

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $2,007 of the $2,802 with a category attached, or 71.6%. 6 manufacturers reported payments, led by Medtronic at 43.8% of the total. Reporting peaked in 2022 at $1,192 and has fallen 96.0% since, to $48 in 2025. That places this record below the midpoint for interventional pain medicine clinicians in VA, where the typical reported total is $4,360.

$2,802in general payments, 2019–2025

Across 35 payments — averaging $80.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$1K
  • Spinal Simplicity, LLC$1K
  • Nevro Corp.$212
  • Boston Scientific$122
  • Abbott$34
  • Si-bone, Inc.$26

What the payments were for

  • Travel & lodging$2,00772%
  • Food & beverage$79628%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic12$1,228
Spinal Simplicity, LLC13$1,181
Nevro Corp.6$212
Boston Scientific2$122
Abbott1$34
Si-bone, Inc.1$26

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,802 in reported general payments places this provider in the 35th percentile of 52 interventional pain medicine providers in Virginia.

See all interventional pain medicine providers in Virginia

Medicare billing

Part B allowed, 2024
$89,026
Medicare patients
271
Services billed
3,290

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Xtampza ErOxycodone Myristate21$11,031
MovantikNaloxegol Oxalate14$8,043
BelbucaBuprenorphine Hcl11$6,545
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen168$5,678
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen137$3,564
Oxycodone Hcl175$3,151
Buprenorphine13$3,046
Morphine Sulfate ErMorphine Sulfate24$628
Tizanidine Hcl40$451
Gabapentin37$349
Pregabalin15$329
Tramadol Hcl33$204
Cyclobenzaprine Hcl19$150
Prednisone35$89
Meloxicam16$37

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Virginia Beach

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →